Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.
The global Pulmonary Drug Delivery Systems market is projected to grow from US$ 3184.9 million in 2024 to US$ 4076.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.
The major players in global Pulmonary Drug Delivery Systems market include 3M, GSK, AstraZeneca, etc. The top 3 players occupy about 60% shares of the global market. Europe and North America are main markets, they occupy over 75% of the global market. Metered Dose Inhaler (MDI) is the main type, with a share over 60%. COPD is the main application, which holds a share over 50%.
Report Covers:
This report presents an overview of global market for Pulmonary Drug Delivery Systems, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pulmonary Drug Delivery Systems, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pulmonary Drug Delivery Systems, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pulmonary Drug Delivery Systems sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pulmonary Drug Delivery Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pulmonary Drug Delivery Systems sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing
Segment by Type
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)
Segment by Application
COPD
Asthma
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pulmonary Drug Delivery Systems in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pulmonary Drug Delivery Systems manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pulmonary Drug Delivery Systems sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Pulmonary Drug Delivery Systems Product Introduction
1.2 Market by Type
1.2.1 Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Nebulizers
1.2.3 Dry Powder Inhaler (DPI)
1.2.4 Metered Dose Inhaler (MDI)
1.3 Market by Application
1.3.1 Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 COPD
1.3.3 Asthma
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pulmonary Drug Delivery Systems Sales Estimates and Forecasts 2019-2030
2.2 Global Pulmonary Drug Delivery Systems Revenue by Region
2.2.1 Global Pulmonary Drug Delivery Systems Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Pulmonary Drug Delivery Systems Revenue by Region (2019-2024)
2.2.3 Global Pulmonary Drug Delivery Systems Revenue by Region (2025-2030)
2.2.4 Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2019-2030)
2.3 Global Pulmonary Drug Delivery Systems Sales Estimates and Forecasts 2019-2030
2.4 Global Pulmonary Drug Delivery Systems Sales by Region
2.4.1 Global Pulmonary Drug Delivery Systems Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Pulmonary Drug Delivery Systems Sales by Region (2019-2024)
2.4.3 Global Pulmonary Drug Delivery Systems Sales by Region (2025-2030)
2.4.4 Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pulmonary Drug Delivery Systems Sales by Manufacturers
3.1.1 Global Pulmonary Drug Delivery Systems Sales by Manufacturers (2019-2024)
3.1.2 Global Pulmonary Drug Delivery Systems Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pulmonary Drug Delivery Systems in 2023
3.2 Global Pulmonary Drug Delivery Systems Revenue by Manufacturers
3.2.1 Global Pulmonary Drug Delivery Systems Revenue by Manufacturers (2019-2024)
3.2.2 Global Pulmonary Drug Delivery Systems Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pulmonary Drug Delivery Systems Revenue in 2023
3.3 Global Key Players of Pulmonary Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Pulmonary Drug Delivery Systems Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pulmonary Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pulmonary Drug Delivery Systems, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pulmonary Drug Delivery Systems, Product Offered and Application
3.8 Global Key Manufacturers of Pulmonary Drug Delivery Systems, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pulmonary Drug Delivery Systems Sales by Type
4.1.1 Global Pulmonary Drug Delivery Systems Historical Sales by Type (2019-2024)
4.1.2 Global Pulmonary Drug Delivery Systems Forecasted Sales by Type (2025-2030)
4.1.3 Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2019-2030)
4.2 Global Pulmonary Drug Delivery Systems Revenue by Type
4.2.1 Global Pulmonary Drug Delivery Systems Historical Revenue by Type (2019-2024)
4.2.2 Global Pulmonary Drug Delivery Systems Forecasted Revenue by Type (2025-2030)
4.2.3 Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2019-2030)
4.3 Global Pulmonary Drug Delivery Systems Price by Type
4.3.1 Global Pulmonary Drug Delivery Systems Price by Type (2019-2024)
4.3.2 Global Pulmonary Drug Delivery Systems Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Pulmonary Drug Delivery Systems Sales by Application
5.1.1 Global Pulmonary Drug Delivery Systems Historical Sales by Application (2019-2024)
5.1.2 Global Pulmonary Drug Delivery Systems Forecasted Sales by Application (2025-2030)
5.1.3 Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2019-2030)
5.2 Global Pulmonary Drug Delivery Systems Revenue by Application
5.2.1 Global Pulmonary Drug Delivery Systems Historical Revenue by Application (2019-2024)
5.2.2 Global Pulmonary Drug Delivery Systems Forecasted Revenue by Application (2025-2030)
5.2.3 Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2019-2030)
5.3 Global Pulmonary Drug Delivery Systems Price by Application
5.3.1 Global Pulmonary Drug Delivery Systems Price by Application (2019-2024)
5.3.2 Global Pulmonary Drug Delivery Systems Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Pulmonary Drug Delivery Systems Market Size by Type
6.1.1 US & Canada Pulmonary Drug Delivery Systems Sales by Type (2019-2030)
6.1.2 US & Canada Pulmonary Drug Delivery Systems Revenue by Type (2019-2030)
6.2 US & Canada Pulmonary Drug Delivery Systems Market Size by Application
6.2.1 US & Canada Pulmonary Drug Delivery Systems Sales by Application (2019-2030)
6.2.2 US & Canada Pulmonary Drug Delivery Systems Revenue by Application (2019-2030)
6.3 US & Canada Pulmonary Drug Delivery Systems Market Size by Country
6.3.1 US & Canada Pulmonary Drug Delivery Systems Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Pulmonary Drug Delivery Systems Sales by Country (2019-2030)
6.3.3 US & Canada Pulmonary Drug Delivery Systems Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pulmonary Drug Delivery Systems Market Size by Type
7.1.1 Europe Pulmonary Drug Delivery Systems Sales by Type (2019-2030)
7.1.2 Europe Pulmonary Drug Delivery Systems Revenue by Type (2019-2030)
7.2 Europe Pulmonary Drug Delivery Systems Market Size by Application
7.2.1 Europe Pulmonary Drug Delivery Systems Sales by Application (2019-2030)
7.2.2 Europe Pulmonary Drug Delivery Systems Revenue by Application (2019-2030)
7.3 Europe Pulmonary Drug Delivery Systems Market Size by Country
7.3.1 Europe Pulmonary Drug Delivery Systems Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Pulmonary Drug Delivery Systems Sales by Country (2019-2030)
7.3.3 Europe Pulmonary Drug Delivery Systems Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pulmonary Drug Delivery Systems Market Size
8.1.1 China Pulmonary Drug Delivery Systems Sales (2019-2030)
8.1.2 China Pulmonary Drug Delivery Systems Revenue (2019-2030)
8.2 China Pulmonary Drug Delivery Systems Market Size by Application
8.2.1 China Pulmonary Drug Delivery Systems Sales by Application (2019-2030)
8.2.2 China Pulmonary Drug Delivery Systems Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pulmonary Drug Delivery Systems Market Size by Type
9.1.1 Asia Pulmonary Drug Delivery Systems Sales by Type (2019-2030)
9.1.2 Asia Pulmonary Drug Delivery Systems Revenue by Type (2019-2030)
9.2 Asia Pulmonary Drug Delivery Systems Market Size by Application
9.2.1 Asia Pulmonary Drug Delivery Systems Sales by Application (2019-2030)
9.2.2 Asia Pulmonary Drug Delivery Systems Revenue by Application (2019-2030)
9.3 Asia Pulmonary Drug Delivery Systems Sales by Region
9.3.1 Asia Pulmonary Drug Delivery Systems Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Pulmonary Drug Delivery Systems Revenue by Region (2019-2030)
9.3.3 Asia Pulmonary Drug Delivery Systems Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pulmonary Drug Delivery Systems Market Size by Type
10.1.1 Middle East, Africa and Latin America Pulmonary Drug Delivery Systems Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Pulmonary Drug Delivery Systems Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Pulmonary Drug Delivery Systems Market Size by Application
10.2.1 Middle East, Africa and Latin America Pulmonary Drug Delivery Systems Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Pulmonary Drug Delivery Systems Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Pulmonary Drug Delivery Systems Sales by Country
10.3.1 Middle East, Africa and Latin America Pulmonary Drug Delivery Systems Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Pulmonary Drug Delivery Systems Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Pulmonary Drug Delivery Systems Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 3M
11.1.1 3M Company Information
11.1.2 3M Overview
11.1.3 3M Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 3M Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 3M Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 GSK Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Overview
11.3.3 AstraZeneca Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 AstraZeneca Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AstraZeneca Recent Developments
11.4 Cipla
11.4.1 Cipla Company Information
11.4.2 Cipla Overview
11.4.3 Cipla Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Cipla Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cipla Recent Developments
11.5 Chiesi
11.5.1 Chiesi Company Information
11.5.2 Chiesi Overview
11.5.3 Chiesi Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Chiesi Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chiesi Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Overview
11.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Aptar
11.7.1 Aptar Company Information
11.7.2 Aptar Overview
11.7.3 Aptar Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Aptar Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aptar Recent Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Overview
11.8.3 Novartis Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Novartis Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis Recent Developments
11.9 Philips Respironics
11.9.1 Philips Respironics Company Information
11.9.2 Philips Respironics Overview
11.9.3 Philips Respironics Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Philips Respironics Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Philips Respironics Recent Developments
11.10 Omron Healthcare
11.10.1 Omron Healthcare Company Information
11.10.2 Omron Healthcare Overview
11.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Omron Healthcare Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Omron Healthcare Recent Developments
11.11 PARI
11.11.1 PARI Company Information
11.11.2 PARI Overview
11.11.3 PARI Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 PARI Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 PARI Recent Developments
11.12 Skyepharma
11.12.1 Skyepharma Company Information
11.12.2 Skyepharma Overview
11.12.3 Skyepharma Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Skyepharma Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Skyepharma Recent Developments
11.13 CareFusion
11.13.1 CareFusion Company Information
11.13.2 CareFusion Overview
11.13.3 CareFusion Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 CareFusion Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 CareFusion Recent Developments
11.14 Shanghai Huarui
11.14.1 Shanghai Huarui Company Information
11.14.2 Shanghai Huarui Overview
11.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Shanghai Huarui Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Shanghai Huarui Recent Developments
11.15 Taian Character
11.15.1 Taian Character Company Information
11.15.2 Taian Character Overview
11.15.3 Taian Character Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Taian Character Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Taian Character Recent Developments
11.16 Chia Tai Tianqing
11.16.1 Chia Tai Tianqing Company Information
11.16.2 Chia Tai Tianqing Overview
11.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Chia Tai Tianqing Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pulmonary Drug Delivery Systems Industry Chain Analysis
12.2 Pulmonary Drug Delivery Systems Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pulmonary Drug Delivery Systems Production Mode & Process
12.4 Pulmonary Drug Delivery Systems Sales and Marketing
12.4.1 Pulmonary Drug Delivery Systems Sales Channels
12.4.2 Pulmonary Drug Delivery Systems Distributors
12.5 Pulmonary Drug Delivery Systems Customers
13 Market Dynamics
13.1 Pulmonary Drug Delivery Systems Industry Trends
13.2 Pulmonary Drug Delivery Systems Market Drivers
13.3 Pulmonary Drug Delivery Systems Market Challenges
13.4 Pulmonary Drug Delivery Systems Market Restraints
14 Key Findings in The Global Pulmonary Drug Delivery Systems Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
3M
GSK
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing
听
听
*If Applicable.
